Skip to content

Efficacy and Safety of Optimal Muscle Tension Management During Laparoscopic Cholecystectomy

Efficacy and Safety of Optimal Muscle Tension Management During Laparoscopic Cholecystectomy - a Prospective Randomized Control Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04165057
Enrollment
70
Registered
2019-11-15
Start date
2020-01-01
Completion date
2020-12-31
Last updated
2019-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Keywords

Laparoscopic surgery, Optimal muscle tension, Neuromuscular monitoring, Neuromuscular blockade, Sugammadex

Brief summary

Our study is intended to compare optimal muscle tension management or conventional anesthetic management in laparoscopic cholecystectomy about surgical condition during the surgery and other conditions after surgery at POR.

Detailed description

This study is intended to recruit 70 patients undergoing laparoscopic cholecystectomy, whom will be randomized to receive optimal muscle tension management or conventional anesthetic management without optimal muscle tension management. Our primary hypothesis is that optimal muscle tension management provides improved surgical conditions and less intra-abdominal pressure required. The secondary endpoints include surgical duration, intraoperative complications, total amount of muscle relaxants, respiratory and hemodynamic changes during surgery, extubation time and any events during post-anesthetic recovery.

Interventions

OTHEROptimal muscle tension management

including TOF monitor and reversal of neuromuscular blockade agent : sugammadex

Sponsors

National Taiwan University Hospital Hsin-Chu Branch
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

Single Blind

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* age 20\ 80 years old * ASA score : 1-2 * Regular laparoscopic cholecystectomy

Exclusion criteria

* Renal function impairement (eGFR \< 60 ml/min/1.73m2) or ESRD * BMI \< 18.5 kg/m2 or \>30 kg/m2 * History of other abdominal surgery * Allergy to rocuronium, cisatracurium, neostigmine or sugammadex * Emergent surgery * Convert to open cholecystectomy

Design outcomes

Primary

MeasureTime frameDescription
Surgical condition5 minutesSurgeon describe CO2 inflation condition by 4 point King Score (1-4). 1. excellent 2. good 3. acceptable 4. poor or unacceptable

Secondary

MeasureTime frameDescription
Mean blood pressureEvery 5 minsMean blood pressure during the CO2 inflation
Total surgical time1 hourTotal surgical time
Total Rocuronium doses during surgery1 hourTotal Rocuronium doses during surgery
Peak inspiratory pressure during surgery1 hourPeak inspiratory pressure during surgery
Heart Rateevery 5 minsEvery beat per minutes heart rate during CO2 inflation
Respiratory complicationsEvery 5 minsRecord any respiratory complications including desaturations (\<95%, more than 30 seconds, Rispiratory rate \< 8), aspiration or airway obstruction
Pain score at Postoperative room1 hourdescribe by 11 points Numeric rating scales (0-10). From 0 which means no pain to 10 means worst pain

Countries

Taiwan

Contacts

Primary ContactYI-PING WANG, MD
joesph0502@gmail.com+886-3-5326151

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026